ABSTRACT Extracts from lymphoid and fibroblast cell lines transformed by Abelson murine leukemia virus (A-MuLV) contain a protein of molecular weight 120,000 (PI20). Immunoprecipitation with specific sera shows that P120 contains regions homologous to the 5'-terminal segment of the MuLV gag gene complex-p15, p12, and at least part of p30-but lacks detectable determinants of plO, reverse transcriptase, and the envelope glycoprotein. P120 is phosphorylated and has an intracellular half-life of 3-6 hr. In vitro translation of virion RNA from A-MuLV, with Moloney MuLV as helper, yields a product of molecular weight 120,000 with serological reactivity similar to that of the cellular P120. Translation of the RNA from the helper gave no P120. P120 is expressed in all lymphoid and fibroblastic cell lines we have tested that were transformed by A-MuLV but is not detectable in a lymphoid line in which the A-MuLV genome was established by infection but was not responsible for the transformation. Expression of P120 is selectively retained in clones of A-MuLV-transformed lymphocytes that convert to a nonproducer state after loss of expression of helper MuLV intracellular precursors. These results suggest that the P120 product of the A-MuLV genome may be responsible for maintenance of the transforme phenotype of lymphoid and fibroblast cells transformed by the virus. Abelson murine leukemia virus (A-MuLV) is a defective leukemia-inducing retrovirus. It was originally isolated from a corticosteroid-treated mouse infected with Moloney murine leukemia virus (M-MuLV) and it generally induces a thymusindependent lymphoma within a short period (3-6 weeks) after in vivo inoculation (1). A-MuLV will transform a subpopulation of bone marrow cells in vitro (2) MuLV. The nature of this interaction is not understood but it appears that the helper plays a role at least for the induction of lymphoid cell transformation.
fibroblast cells transformed by the virus. Abelson murine leukemia virus (A-MuLV) is a defective leukemia-inducing retrovirus. It was originally isolated from a corticosteroid-treated mouse infected with Moloney murine leukemia virus (M-MuLV) and it generally induces a thymusindependent lymphoma within a short period (3) (4) (5) (6) weeks) after in vivo inoculation (1) . A-MuLV will transform a subpopulation of bone marrow cells in vitro (2) and the resulting lines often contain immunoglobulins (3, 4) . These and other results suggest that A-MuLV specifically transforms cells of the B lymphocyte lineage (5) (6) (7) .
A-MuLV is capable of transforming established fibroblastic cell lines. Like the defective murine sarcoma viruses, it requires a helper MuLV to provide essential structural components for its replication and for production of infectious virions but transformed cell lines lacking evidence of replication of the helper virus can be isolated (nonproducer transformed fibroblasts) (8, 9) .
Although any replicating MuLV appears to be able to act as a helper for fibroblast transformation, the interaction of AMuLV with lymphoid target cells is more complex. Recently, Rosenberg and Baltimore (10) and Scher (11) have demonstrated that the successful transformation of lymphoid cells by A-MuLV is dependent on the strain of helper MuLV used. Only strains of MuLV that are themselves highly leukemogenic are efficiently able to provide the helper functions necessary for in vivo and in vitro transformation of lymphoid cells by A- MuLV. The nature of this interaction is not understood but it appears that the helper plays a role at least for the induction of lymphoid cell transformation.
We have initiated a search for gene products in A-MuLVtransformed cells that could play a role in the transformation process. By immunoprecipitation of labeled cellular extracts we have found a unique protein of molecular weight 120,000 (P120) that bears partial serological homology to certain of the MuLV gene products. The presence of P120 in lymphoid and fibroblast nonproducer cells transformed by A-MuLV, coupled with its cell-free translation from A-MuLV virion RNA, suggests that P120 is a product of the Abelson genome that may be involved in the induction or maintenance of the transformed state.
MATERIALS AND METHODS Cells and Viruses. Lymphoid cell lines transformed in vitro by A-MuLV were isolated from individual bone marrow colonies by using the agarose transformation assay previously described (2 for 30 min. Cells were extracted and immunoprecipitated as detailed elsewhere (16) . Briefly, cells at 1-2 X 106/ml were lysed with 1% Triton X-100/0.5% deoxycholate/0.1% sodium dodecyl sulfate (NaDodSO4)/0.01 M NaH2PO4, Na2HPO4/0.1 M NaCl, pH 7.5) precleared with normal serum and Staphylococcus aureus Cowan strain 1 (17) , and then clarified. Immunoprecipitates were made by incubating up to 1 ml of lysate with 5 /Jl of immune serum and then collecting antigen-antibody complexes with S. aureus. 14C-Amino acid-labeled MMuLV virions were prepared as described (18) . NaDodSO4/Polyacrylamide Gel Electrophoresis. Immunoprecipitates and other samples were denatured in 1% NaDodSO4/1% 2-mercaptoethanol/50 mM Tris-HCl, pH 6.8/10% glycerol and electrophoresed on 20-5% linear polyacrylamide gradient gels as described (19, 20) . Gels were fixed and fluorographed as described (21) .
Molecular weight estimates were interpolated from known viral proteins of adenovirus type 2 and vesicular stomatitis virus and standard proteins.
RESULTS
Identification of P120 in A-MuLV-Induced Lymphomas. We have screened a number of lymphoma cell lines with a battery of antisera prepared against leukemia virus proteins. To show the specificities of these antisera for virion proteins, e. kcts of purified virions of M-MuLV labeled with mixed "4C-amino acids were immunoprecipitated at antibody excess and the precipitates were fractionated by NaDodSO4/polyacrylamide gel electrophoresis (Fig. 1A) . Lane 1 shows that the anti-reverse transcriptase precipitate contained reverse transcriptase (p85) and the low molecular weight component p15. Note that the migration in NaDodSO4/polyacrylamide gel electrophoresis of p15 is actually close to 9000-10,000 molecular weight. This protein, however, lacks methionine. is not phosphorylated, and can be recovered in the appropriate processing intermediates of the MuLV gag gene (0. N. Witte and D. Baltimore, unpublished data), showing that it is homologous to the NH2-terminal p15 described for Rauscher MuLV (22) . The anti-p15 activity of the anti-RT/p15 antiserum could be adsorbed with purified MuLV low molecular weight (10,000-30,000) proteins without affecting the precipitation of the reverse transcriptase (p85) itself, indicating that separate antibody molecules are responsible for the precipitation of the two proteins (data not shown). Anti-gp7O (lane 2), anti-p3O (lane 3), anti-p15 (lane 4) , anti-p12 (lane 5) , and anti-plO (lane 6) were reactive predominantly with the antigen used to induce the antiserum. Anti-gp7O precipitated pl5E and pl2E because they are attached to gp7O under nonreducing conditions (20) .
To reveal the proteins encoded by M-MuLV in a virus-induced lymphoma, pulse-labeled ([35S]methionine) cellular extracts from the M-MuLV-induced lymphoma B244 were immunoprecipitated (Fig. 1B) . The major viral gene products visualized were the polyproteins Pr65sag and Pr8Oenv (23) . Some cleavage products, such as the virion structural protein p3O, were also evident. When a lymphoid cell line transformed in vitro by A-MuLV plus helper M-MuLV was similarly labeled, extracted, and immunoprecipitated a new component was found. This cell line, called 18-48, was producing both A-MuLV and M-MuLV when it was studied. In spite of this, the labeled extracts contained little of M-MuLV-specific gag polyprotein or its cleavage products (Fig. 1C) . However, the extract had a readily detected protein of 120,000 molecular weight (P120) that was precipitated by the anti-RT/p15 (lane 1) and anti-p3O antisera (lane 3) but not by the anti-gp7O (lane 2). Pr8Oen" was precipitated by the anti-gp7O antiserum. The reactivity of the anti-RT/p15 antisera was removed completely by absorption with low molecular weight proteins of MuLV (data not shown). A second anti-reverse transcriptase antiserum (from T. Papis) did not precipitate P120 although it did precipitate reverse transcriptase (p85) from virions (data not shown). Thus, P120 appears to contain structural information related to the MuLV gag gene products p15 and p3O but lacks detectable homology to the pol and env gene products. A second component, of molecular weight about 110,000, was precipitated by anti-p3O antiserum (Fig. 1C, lane 3 (8) (9) (10) . We tested such a transformed nonproducer line, NIH/3T3-derived A2, for the presence of P120 (Fig. 2A) . Extracts (Fig. 2B) . P120 continued to be expressed in these cells. Proteins corresponding to the MuLV precursors Pr65gag, Pr75gag and Pr8Oeno were also seen (Fig. 2B, lanes 1, 2, and 3) . Similarly, when a lymphoid nonproducer cell line, 143-2M3 derived from the in vitro transformation of bone marrow cells by A-MuLV, was tested, it too contained P120 (Fig. 2C) . Upon superinfection of 143-2M3 with M-MuLV (Fig. 2D) (7) .
To test if P120 is required for A-MuLV replication, as opposed to its apparent necessity for A-MuLV transformation, a cell line transformed by a different agent was infected with A-MuLV and a culture producing both A-MuLV and helper M-MuLV was derived. The host cell was L-691-6, a line derived from a thymic lymphoma caused by x-irradiation in vivo (13) . L691-6 bears the surface antigen and has the biological characteristics of a thymus-derived lymphoma (7, 13). It produces a xenotropic retrovirus but no detectable ecotropic MuLV. We (Fig. 2E ), L691-6/M (Fig. 2F) , and L691-6/AM (Fig. 2G) were immunoprecipitated with specific sera. None of the cell lines contained P120. This included L691-6/AM which was found to replicate and produce infectious, oncogenic A-MuLV particles (Table 1 ). L691-6/M and L691-6/AM both contained intracellular precursors of MMuLV (Pr65gag and Pr8Oenv). Although these results do not eliminate the possibility that very small amounts of P120 may be produced and provide an essential function for A-MuLV replication, reconstruction experiments indicate that L691-6/AM cells express less than 5% of the level of P120 found in lymphoid cell lines (such as line 18-48) transformed by AMuLV. We therefore conclude that P120 is probably not required for productive A-MuLV infection.
In Vitro Translation of P120 from A-MuLV Virion RNA.
To determine if the A-MuLV genome can direct synthesis of P120 in a cell-free system, 60-70S RNA was purified from a mixture of A-MuLV and M-MuLV harvested from a transformed fibroblast cell line, and the RNA was heat denatured to yield 30-38S subunits. As a control, pure 38S MuLV RNA (a kind gift of P. Andersson) was translated. Fractions precipitated from ethanol were used for translation in the mRNA-dependent reticulocyte lysate system (14, 15) . Fig. 3A shows the pattern of total synthesis for the M-MuLV RNA preparation. No P120 was evident and the previously described viral components corresponding to Pr65gag and Pr75gag were the major translation products (15) . When A-MuLV virion RNA was translated (Fig. 3B) , an additional band of molecular weight 120,000 was detected which comigrated with P120 immunoprecipitated from cellular lysate. Immunoprecipitation with anti-RT/p15 (Fig. 3C) showed that the cell-free product had the same serological reactivity as the intracellular P120. P120, Pr8Oenv, and Pr65gag immunoprecipitated from cellular lysates (Fig.   3D ) are shown as markers. These results show that the A-MuLV HaM/ICR CD-1 BALB/cJ * Virus production was monitored by using infectivity and reverse transcriptase assays according to standard procedures (2, 10). PFU were measured by using the S+L-assay (24); FFU were monitored by using the NIH/3T3 or BALB/3T3 focus assay (8 cells were subcloned and the clones were tested individually for biological activity, only one in five produced high titers of infectious virus. The intracellular proteins expressed in the four nonproducer subclones (18-48-1, -2, -3, and -5) (<10 FFU/ml) and one producer subclone (18-48-4) (>104 FFU/ml) were assayed. Pulse-labeled cellular extracts were immunoprecipitated with an antiserum prepared against disrupted M-MuLV virions that had specificity for gag and env gene products (Fig. 4) . All of the subclones retained the expression of P120 Our serological data imply that the A-MuLV genome encodes some but not all of the gag proteins of its parent, MMuLV. The 5'-terminal portions of the gag polyprotein (Pr65gaS), p15 and p12, are represented in P120, and our MMuLV-specific anti-p,30 recognizes P120 also. Previous studies found p15 and p12 but not p30 determinants among the AMuLV-specified products (9) and we have also found an antip30 antiserum that will not recognize P120. We therefore believe that P120 results from a fusion of the 5' end of the MMuLV genome somewhere within the p30 coding region to a genetic region of undetermined origin. Although 30,000-5,000 daltons of P120 are M-MuLV in origin, the rest has no antigenicity that we can yet define. No anti-RT or anti-gp7O antiserum can recognize P120 (except in the case of the strong antip15 reactivity of our anti-RT antiserum) and we therefore believe that the A-MuLV genome probably has a genetic region not found in M-MuLV.
Comparison of P120 to the gene products of several other defective leukemia/sarcoma viruses in the retrovirus group shows interesting parallels. Murine sarcoma virus P60 (26) , avian virus MC29 P110 (27) , and feline sarcoma virus FOCMA antigen (90,000-100,000 molecular weight) (28) all contain some structural homology to the 5' end of the gag gene of the original helper virus from which they were isolated. Thus, oncogenic retroviruses may often arise from fusion of the 5'-terminal portion of the gag region with other genetic material.
Although P120 is quite possibly responsible for fibroblast transformation by A-MuLV, the evidence for a helper function in A-MuLV lymphoid cell transformation implies that P120 is not sufficient to explain lymphoid transformation. Because no M-MuLV protein was evident in nonproducer lymphoid transformants, a role for the helper in maintenance of the transformed state is not indicated and it may be needed only for establishing transformation.
In cells producing A-MuLV and helper MuLV, the P120 is very stable intracellularly during pulse-chase experiments with a half-life of 3-6 hr. Only a small fraction can be recovered in the supernatant medium and only a fraction of this is found in the particulate fraction containing virus (unpublished data). No defined cleavage products of P120 are seen to accumulate intracellularly but only those retaining MuLV antigenicity could be recovered in these experiments. Preliminary cell fractionation studies have recovered a large fraction (80-90%) of P120 in membrane-bound form but we are as yet uncertain how much, if any, is found on the cell surface. 
